+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Bromhidrosis Disease Treatment Market - Global Forecast 2025-2030- Product Image
Bromhidrosis Disease Treatment Market - Global Forecast 2025-2030- Product Image
Sale

Bromhidrosis Disease Treatment Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 190 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6011459
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The bromhidrosis disease treatment market is evolving as innovations in therapies, shifting patient expectations, and regulatory dynamics converge to create opportunities and complexities for industry stakeholders and healthcare decision-makers. Demand for holistic, patient-centric management drives a nuanced and rapidly advancing competitive landscape.

Market Snapshot: Bromhidrosis Disease Treatment Market Overview

The Bromhidrosis Disease Treatment Market grew from USD 489.03 million in 2024 to USD 536.67 million in 2025. It is expected to continue its positive trajectory at a CAGR of 9.47%, reaching USD 841.86 million by 2030. Rising awareness, advancing noninvasive therapies, and an expanding base of patient needs underscore the market’s momentum. Providers are recalibrating business models to keep pace with both technological advancements and evolving consumer preferences.

Scope & Segmentation of the Bromhidrosis Treatment Ecosystem

This report comprehensively analyzes multiple segments and regional influences across the value chain, highlighting pivotal growth drivers, competitive differentiators, and regulatory complexities. Segmentation reflects current trends and future strategic opportunities:

  • Product Types: Antiperspirants (cream, roll-on, spray, stick), Botulinum toxin therapies (AbobotulinumtoxinA, IncobotulinumtoxinA, OnabotulinumtoxinA), Iontophoresis devices (portable, stationary), Surgical procedures (curettage, endoscopic thoracic sympathectomy, local excision)
  • Modes of Administration: Injectable interventions (intradermal, subcutaneous), Topical applications (cream, gel, roll-on, spray)
  • Distribution Channels: E-commerce, hospital pharmacies, retail pharmacies, specialty clinics
  • End Users: Dermatology clinics (chain, independent), home care, private and public hospitals
  • Regions: Americas, Europe, Middle East, Africa, Asia-Pacific, with focused analysis on key countries within each area
  • Technologies: Next-generation botulinum toxins, portable iontophoresis, advanced digital health platforms, antimicrobial topical agents

Key Takeaways for Senior Decision-Makers

  • Broad market expansion is driven by rising expectations for patient-centric, convenient treatment regimens alongside traditional over-the-counter products and procedural solutions.
  • Regulatory shifts and reimbursement changes directly influence the pace of therapeutic development and global market access, requiring faster adaptation of business and distribution strategies.
  • Integrated care pathways, leveraging both in-clinic and remote digital health services, are becoming standard practice across leading clinics and emerging markets.
  • Strategic collaborations among device manufacturers, pharmaceutical companies, and digital health providers accelerate R&D, commercialization, and real-world data collection.
  • The emergence of differentiated product portfolios—such as combination therapies and portable devices—align with evolving end-user needs and channel-specific opportunities.
  • Regional differentiation remains crucial as local regulations, cultural attitudes, and distribution networks determine adoption rates and competitive positioning.

Tariff Impact: Adjusting to New Regulatory Realities

Recent United States tariff adjustments on raw materials and pharmaceutical-grade ingredients have created additional cost pressures and supply chain complexities for manufacturers in the bromhidrosis treatment sector. Companies are reconsidering sourcing strategies, production locations, and inventory approaches to navigate these changes. The ripple effects influence contract negotiations, payer pricing, and ultimately treatment accessibility across various care settings. Proactive forecasting and scenario modeling now play a greater role in overall risk mitigation.

Methodology & Data Sources

This report employs a rigorous multi-step research methodology combining secondary data from peer-reviewed journals, clinical registries, and industry publications, with primary interviews from key opinion leaders including dermatologists, pharmacists, surgeons, and health economics professionals. Qualitative insights were corroborated via triangulation with real-world market data and distribution partner feedback, ensuring robust and actionable intelligence throughout each phase of the analysis.

Why This Report Matters to the Bromhidrosis Disease Treatment Market

  • Empowers decision-makers to anticipate emerging challenges and capture new opportunities in a complex, multi-segmented marketplace.
  • Provides granular analysis across technology, segmentation, and regional variables, supporting strategy refinement and investment planning.
  • Delivers actionable insights tailored specifically to senior leaders seeking to optimize product portfolios, business models, and cross-functional partnerships.

Conclusion

The bromhidrosis disease treatment market is entering a phase of sustained innovation, driven by patient needs, cross-sector collaboration, and policy shifts. This report provides a clear roadmap for stakeholders to inform strategic action, achieve growth, and improve patient outcomes globally.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growth of minimally invasive ultrasound technology for targeted sweat gland ablation in bromhidrosis treatment
5.2. Rising consumer demand for natural and organic topical formulations addressing underarm odor management
5.3. Adoption of radiofrequency devices combined with injectable neuromodulators to enhance bromhidrosis outcomes
5.4. Expansion of personalized treatment plans based on sweat gland density mapping and genetic profiling
5.5. Integration of teledermatology platforms for remote diagnosis and management of bromhidrosis symptoms
5.6. Development of long-acting botulinum toxin formulations offering extended relief from excessive underarm sweating
5.7. Collaboration between skincare brands and influencers to drive awareness of new bromhidrosis therapies
5.8. Clinical trials exploring novel peptide inhibitors targeting eccrine gland secretions for odor control
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Bromhidrosis Disease Treatment Market, by Product Type
8.1. Introduction
8.2. Antiperspirants
8.2.1. Cream
8.2.2. Roll-On
8.2.3. Spray
8.2.4. Stick
8.3. Botulinum Toxin
8.3.1. AbobotulinumtoxinA
8.3.2. IncobotulinumtoxinA
8.3.3. OnabotulinumtoxinA
8.4. Iontophoresis
8.4.1. Portable Devices
8.4.2. Stationary Devices
8.5. Surgery
8.5.1. Curettage
8.5.2. Endoscopic Thoracic Sympathectomy
8.5.3. Local Excision
9. Bromhidrosis Disease Treatment Market, by Mode Of Administration
9.1. Introduction
9.2. Injectable
9.2.1. Intradermal
9.2.2. Subcutaneous
9.3. Topical
9.3.1. Cream
9.3.2. Gel
9.3.3. Roll-On
9.3.4. Spray
10. Bromhidrosis Disease Treatment Market, by Distribution Channel
10.1. Introduction
10.2. E-Commerce
10.3. Hospital Pharmacy
10.4. Retail Pharmacy
10.5. Specialty Clinics
11. Bromhidrosis Disease Treatment Market, by End User
11.1. Introduction
11.2. Dermatology Clinics
11.2.1. Chain Clinics
11.2.2. Independent Clinics
11.3. Home Care
11.4. Hospitals
11.4.1. Private Hospitals
11.4.2. Public Hospitals
12. Americas Bromhidrosis Disease Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Bromhidrosis Disease Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Bromhidrosis Disease Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Bausch Health Companies Inc.
15.3.2. Miramar Labs, Inc.
15.3.3. Merck & Co., Inc.
15.3.4. Medytox, Inc.
15.3.5. Ipsen Pharma S.A.S.
15.3.6. Cutera, Inc.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. BROMHIDROSIS DISEASE TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 8. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 10. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. BROMHIDROSIS DISEASE TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. BROMHIDROSIS DISEASE TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. BROMHIDROSIS DISEASE TREATMENT MARKET: RESEARCHAI
FIGURE 24. BROMHIDROSIS DISEASE TREATMENT MARKET: RESEARCHSTATISTICS
FIGURE 25. BROMHIDROSIS DISEASE TREATMENT MARKET: RESEARCHCONTACTS
FIGURE 26. BROMHIDROSIS DISEASE TREATMENT MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. BROMHIDROSIS DISEASE TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ROLL-ON, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ROLL-ON, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STICK, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STICK, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ABOBOTULINUMTOXINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INCOBOTULINUMTOXINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ONABOTULINUMTOXINA, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATIONARY DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATIONARY DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CURETTAGE, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CURETTAGE, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ENDOSCOPIC THORACIC SYMPATHECTOMY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ENDOSCOPIC THORACIC SYMPATHECTOMY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY LOCAL EXCISION, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY LOCAL EXCISION, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INTRADERMAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INTRADERMAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CREAM, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY GEL, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY GEL, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ROLL-ON, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ROLL-ON, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPRAY, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY E-COMMERCE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CHAIN CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY CHAIN CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INDEPENDENT CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOME CARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 103. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 104. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 105. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2024 (USD MILLION)
TABLE 106. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2025-2030 (USD MILLION)
TABLE 107. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 108. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 109. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2024 (USD MILLION)
TABLE 110. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2025-2030 (USD MILLION)
TABLE 111. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 112. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 113. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 114. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 115. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 116. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 117. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 118. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 119. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 120. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 121. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 122. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 123. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2024 (USD MILLION)
TABLE 124. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2025-2030 (USD MILLION)
TABLE 125. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 126. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 127. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. AMERICAS BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2024 (USD MILLION)
TABLE 132. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2025-2030 (USD MILLION)
TABLE 133. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 134. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 135. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2024 (USD MILLION)
TABLE 136. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2025-2030 (USD MILLION)
TABLE 137. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 138. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 139. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 142. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 143. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 144. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 145. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 146. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 147. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2024 (USD MILLION)
TABLE 150. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2025-2030 (USD MILLION)
TABLE 151. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 152. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 153. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 154. UNITED STATES BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 155. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 156. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 157. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2024 (USD MILLION)
TABLE 158. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2025-2030 (USD MILLION)
TABLE 159. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 160. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 161. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2024 (USD MILLION)
TABLE 162. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2025-2030 (USD MILLION)
TABLE 163. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 164. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 165. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 166. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 167. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 168. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 169. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 170. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 171. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 172. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 173. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 174. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 175. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2024 (USD MILLION)
TABLE 176. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2025-2030 (USD MILLION)
TABLE 177. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 178. CANADA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 179. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 180. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 181. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2024 (USD MILLION)
TABLE 182. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2025-2030 (USD MILLION)
TABLE 183. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 184. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 185. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2024 (USD MILLION)
TABLE 186. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2025-2030 (USD MILLION)
TABLE 187. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 188. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 189. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 192. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 193. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 194. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 195. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 196. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 197. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2024 (USD MILLION)
TABLE 200. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2025-2030 (USD MILLION)
TABLE 201. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 202. MEXICO BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 203. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 204. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 205. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2024 (USD MILLION)
TABLE 206. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2025-2030 (USD MILLION)
TABLE 207. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 208. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 209. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2024 (USD MILLION)
TABLE 210. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2025-2030 (USD MILLION)
TABLE 211. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 212. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 213. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 214. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 215. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 216. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 217. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 218. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 219. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2024 (USD MILLION)
TABLE 224. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2025-2030 (USD MILLION)
TABLE 225. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 226. BRAZIL BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 227. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 228. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 229. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2024 (USD MILLION)
TABLE 230. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2025-2030 (USD MILLION)
TABLE 231. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 232. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 233. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2024 (USD MILLION)
TABLE 234. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2025-2030 (USD MILLION)
TABLE 235. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 236. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 237. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 238. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 239. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 240. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 241. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 242. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 243. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 246. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 247. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2024 (USD MILLION)
TABLE 248. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2025-2030 (USD MILLION)
TABLE 249. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 250. ARGENTINA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 251. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 252. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 253. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2024 (USD MILLION)
TABLE 254. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2025-2030 (USD MILLION)
TABLE 255. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 256. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 257. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2024 (USD MILLION)
TABLE 258. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2025-2030 (USD MILLION)
TABLE 259. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 260. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 261. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 262. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 263. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 264. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 265. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 266. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 267. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 268. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 269. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 270. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 271. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2024 (USD MILLION)
TABLE 272. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2025-2030 (USD MILLION)
TABLE 273. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 274. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 275. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 276. EUROPE, MIDDLE EAST & AFRICA BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 277. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2018-2024 (USD MILLION)
TABLE 280. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY ANTIPERSPIRANTS, 2025-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2018-2024 (USD MILLION)
TABLE 282. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY BOTULINUM TOXIN, 2025-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2018-2024 (USD MILLION)
TABLE 284. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY IONTOPHORESIS, 2025-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2018-2024 (USD MILLION)
TABLE 286. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY SURGERY, 2025-2030 (USD MILLION)
TABLE 287. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 288. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY MODE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2018-2024 (USD MILLION)
TABLE 290. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY INJECTABLE, 2025-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2018-2024 (USD MILLION)
TABLE 292. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY TOPICAL, 2025-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 296. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 297. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2018-2024 (USD MILLION)
TABLE 298. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY DERMATOLOGY CLINICS, 2025-2030 (USD MILLION)
TABLE 299. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2018-2024 (USD MILLION)
TABLE 300. UNITED KINGDOM BROMHIDROSIS DISEASE TREATMENT MARKET SIZE, BY HOSPITALS, 2025-2030 (USD MILLION)
TABLE 301. GERMANY BROMHIDROS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Bromhidrosis Disease Treatment market report include:
  • Bausch Health Companies Inc.
  • Miramar Labs, Inc.
  • Merck & Co., Inc.
  • Medytox, Inc.
  • Ipsen Pharma S.A.S.
  • Cutera, Inc.

Table Information

Report AttributeDetails
No. of Pages190
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 536.67 Million
Forecasted Market Value ( USD ) by 2030 $ 841.86 Million
Compound Annual Growth Rate9.4%
Regions CoveredGlobal
No. of Companies Mentioned7

Related Topics

Related Reports

Bromhidrosis Disease Treatment - Global Strategic Business Report - Product Image

Bromhidrosis Disease Treatment - Global Strategic Business Report

  • Report
  • 250 Pages
  • Global
From
Gaucher Disease Treatment Market - Global Forecast 2025-2030 - Product Image

Gaucher Disease Treatment Market - Global Forecast 2025-2030

  • Report
  • 191 Pages
  • Global
From
Krabbe Disease Treatment Market - Global Forecast 2025-2030 - Product Image

Krabbe Disease Treatment Market - Global Forecast 2025-2030

  • Report
  • 196 Pages
  • Global
From
Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031) - Product Image

Global Thyroid Eye Disease Treatment Market (2025 Edition): Analysis By Therapeutic Type (Monoclonal Antibodies, Corticosteroids, Vitamins, and Other Therapies), Route of Administration, Distribution Channel: Market Insights and Forecast (2021-2031)

  • Report
  • 238 Pages
  • Global
From
Diabetes Drug Market Overview, 2025-30 - Product Image

Diabetes Drug Market Overview, 2025-30

  • Report
  • 109 Pages
  • Global
From

About the Market

Bromhidrosis Disease is a condition characterized by an unpleasant body odor caused by excessive sweating. It is classified as an endocrine and metabolic disorder, and is treated with drugs that target the underlying cause of the condition. These drugs are typically used to reduce the production of sweat, regulate hormones, and reduce inflammation. Commonly prescribed drugs include anticholinergics, antiperspirants, and topical corticosteroids. In some cases, oral medications such as antibiotics and antifungals may be prescribed. The Bromhidrosis Disease Drug market is a specialized segment of the Endocrine and Metabolic Disorders Drugs market. It is composed of a variety of drugs used to treat the condition, including anticholinergics, antiperspirants, topical corticosteroids, antibiotics, and antifungals. These drugs are typically prescribed by dermatologists and endocrinologists. Some companies in the Bromhidrosis Disease Drug market include GlaxoSmithKline, Pfizer, Merck, and Novartis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.